In vitro induction of immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell help and is mediated by CD154 up-regulation and inhibition of gamma interferon synthesis

Infection and Immunity

Volumn 75, Issue 3, 2007, Pages 1413-1423

  Arce, Sergio ^a,b   Nawar, Hesham F ^a,b   Muehlinghaus, Gwendolin ^c   Russell, Michael W ^a,b   Connell, Terry D ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c University at Buffalo ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD134 ANTIGEN; CD19 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD45 ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; CHOLERA TOXIN; CONCANAVALIN A; ESCHERICHIA COLI ENTEROTOXIN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SYNDECAN 1;

ANIMAL CELL; ANTIBODY PRODUCING CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; BLAST CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOGLOBULIN PRODUCTION; IMMUNOPHARMACOLOGY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CD40 LIGAND; CELLS, CULTURED; CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PLASMA CELLS; T-LYMPHOCYTES, HELPER-INDUCER; UP-REGULATION;

EID: 33847739402     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01367-06     Document Type: Article

References (45)

1. Agren, L., E. Sverremark, L. Ekman, K. Schon, B. Lowenadler, C. Fernandez, and N. Lycke. 2000. The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic Bcl-2- and germinal center-promoting effects. J. Immunol. 164:6276-6286.
2. Ahmann, G. B., D. H. Sachs, and R. J. Hodes. 1978. Requirement for an Ia-bearing accessory cell in Con A-induced T cell proliferation. J. Immunol. 121:1981-1989.
3. Arce, S., H. F. Nawar, M. W. Russell, and T. D. Connell. 2005. Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells. Infect. Immun. 73:2718-2727.
4. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
5. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-2202.
6. + T lymphocytes generates a costimulatory signal that up-regulates IL-4. J. Immunol. 156:3133-3140.
7. Connell, T. D., S. Cornelia, D. Metzger, and R. T. Evans. 1998. Immunostimulatory activity of LT-IIa, a type II heat-labile enterotoxin of Escherichia coli. Immunol. Lett. 62:117-120.
8. Das, G., D., S. Sheridan, and C. A. Janeway, Jr. 2001. The source of early IFN-γ that plays a role in Th1 priming. J. Immunol. 167:2004-2010.
9. Dillon, S., A. Agrawal, T. Van Dyke, G. Landreth, L. McCauley, A. Koh, C. Maliszewski, S. Akira, and B. Pulendran. 2004. A toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase, mitogen-activated protein kinase and c-fos in dendritic cells. J. Immunol. 172:4733-4743.
10. Dykstra, M. J., A. Cherukuri, H. W. Sohn, S. J. Tzeng, and S. K. Pierce. 2003. Location is everything: lipid rafts and immune cell signaling. Annu. Rev. Immunol. 21:457-481.
11. Flynn, S., K.-M. Toellner, C. Raykundalia, M. Goodall, and P. Lane. 1998. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188:297-304.
12. 1 induces B cell activation. J. Immunol. 148:1999-2007.
13. Fukuta, S., J. L. Magnani, E. M. Twiddy, R. K. Holmes, and V. Ginsburg. 1988. Comparison of the carbohydrate-binding specificities of cholera toxin and Eschericia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb. Infect. Immun. 56:1748-1753.
14. Guth, B. E., E. M. Twiddy, L. R. Trabulsi, and R. K. Holmes. 1986. Variation in chemical properties and antigenic determinants among type II heat-labile enterotoxins of Escherichia coli. Infect. Immun. 54:529-536.
15. Hajishengallis, G., S. Arce, C. M. Gockel, T. D. Connell, and M. W. Russell. 2005. Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections. J. Dent. Res. 84: 1104-1116.
16. Hajishengallis, G., H. Nawar, R. I. Tapping, M. W. Russell, and T. D. Connell. 2004. The type II heat-labile enterotoxins (LT-IIa and LT-IIb) and their respective B pentamers differentially induce and regulate cytokine production in human monocytic cells. Infect. Immun. 72:6351-6358.
17. Hajishengallis, G., R. I. Tapping, M. H. Martin, H. F. Nawar, E. A. Lyle, M. W. Russell, and T. D. Connell. 2005. Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins. Infect. Immun. 73:1343-1349.
18. Hasbold, J., L. M. Corcoran, D. M. Tarlinton, S. G. Tangye, and P. D. Hodgkin. 2004. Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulate lymphocyte differentiation. Nat. Immunol. 5:55-63.
19. Hathcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Hodes. 1994. Comparative analysis of B7.1 and B7.2 costimulatory ligands: expression and function. J. Exp. Med. 180:631-640.
20. Holmes, R. K., M. G. Jobling, and T. D. Connell. 1995. Cholera toxin and related enterotoxins of gram negative bacteria, p. 225-255. In J. Moss, B. Iglewsky, M. Vaughn, and A. T. Tu (ed.), Handbook of natural toxins, 1st ed. Marcel Dekker, Inc., New York, NY.
21. Honda, T., Tsuji, Y. Takeda, and T. Miwatani. 1981. Immunological non-identity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli. Infect. Immun. 34:337-340.
22. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752.
23. + dendritic cells in CD4+ T cell activation in vivo: with help from interleukin 1. J. Exp. Med. 198:185-190.
24. Johnson-Leger, C., J. Christensen, and G. B. Klaus. 1998. CD28 co-stimulation stabilizes expression of the CD40 ligand on T cells. Int. Immunol. 10:1083-1091.
25. Kellar, K. L., R. R. Kalwar, K. A. Dubois, D. Crouse, W. D. Chafin, and B. E. Kane. 2001. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45:27-36.
26. Lycke, N. 1997. The mechanisms of cholera toxin adjuvanticity. Res. Immunol. 148:504-520.
27. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131-137.
28. MacLennan, I. C. M., K. M. Toellner, A. F. Cunningham, K. Serre, D. M. Y. Sze, E. Zuniga, M. C. Cook, and C. G. Vinuesa. 2003. Extrafollicular antibody responses. Immunol. Rev. 194:8-18.
29. Manz, R. A., M. Lohning, G. Cassesse, A. Thiel, and A. Radbruch. 1998. Survival of long-lived plasma cells is independent of antigen. Int. Immunol. 10:1703-1711.
30. Martin, M., D. J. Metzger, S. M. Michalek, T. D. Connell, and M. W. Russell. 2000. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins, LT-IIa and LT-IIb. Infect. Immun. 68:281-287.
31. Mond, J. J., F. D. Finkelman, C. Sarma, J. Ohara, and S. Serrate. 1985. Recombinant interferon-γ inhibits the B cell proliferative response stimulated by soluble but not by sepharose-bound anti-immunoglobulin antibody. J. Immunol. 135:2513-2517.
32. Nagai, Y., and M. Iwamori. 1984. Ganglioside distribution at different levels of organization and its biological implications. Adv. Exp. Med. Biol. 174: 135-136.
33. Nashar, T. O., T. R. Hirst, and N. A. Williams. 1997. Modulation of B-cell activation by the B subunit of Escherichia coli heat-labile enterotoxin: receptor interaction up-regulates MHC-II, B7, CD40, CD25 and ICAM-1. Immunology 91:572-578.
34. Parker, D. C. 1993. T cell-dependent B cell activation. Annu. Rev. Immunol. 11:331-360.
35. Randall, T. D., A. W. Heath, L. Santos-Argumedo, M. C. Howard, I. L. Weissman, and F. E. Lund. 1998. Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity 8:733-742.
36. Reynolds, D. S., W. H. Boom, and A. K. Abbas. 1987. Inhibition of lymphocyte activation by interferon-γ. J. Immunol. 139:767-773.
37. + T cells. J. Immunol. 151:2497-2506.
38. Schmitt-Verhulst, A. M., A. Guimezanes, C. Boyer, M. Poenie, R. Tsien, M. Buferne, C. Hua, and L. Leserman. 1987. Pleiotropic loss of activation pathways in a T-cell receptor α-chain deletion variant of a cytotoxic T-cell clone. Nature 325:628-631.
39. Smith, K. G., T. D. Hewitson, G. J. Nossal, and D. M. Tarlinton. 1996. The phenotype and fate of the antibody-forming cells of the splenic foci. Eur. J. Immunol. 26:444-448.
40. + T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J. Immunol. 165:3136-3144.
41. Snider, D. P. 1995. The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit. Rev. Immunol. 15:317-348.
42. Stuber, E., M. Neurath, D. Calderhead, H. P. Fell, and W. Strober. 1995. Cross-linking of OX-40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2:507-521.
43. Stuber, E., and W. Strober. 1996. The T cell-B cell interaction via OX-40-OX40L is necessary for the T cell-dependent humoral immune response. J. Exp. Med. 183:979-989.
44. van Kooten, C., and J. Banchereau. 2000. CD40-CD40L. J. Leukoc. Biol. 67:2-17.
45. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliot, E. A. Dunn, J. J. Waldschmidt, T. J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40L. Immunity 1:423-431.